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NanoparticlesInclusion bodies (IBs) are protein-based nanoparticles formed in Escherichia coli through stereospecific
aggregation processes during the overexpression of recombinant proteins. In the last years, it has been
shown that IBs can be used as nanostructured biomaterials to stimulate mammalian cell attachment, pro-
liferation, and differentiation. In addition, these nanoparticles have also been explored as natural delivery
systems for protein replacement therapies. Although the production of these protein-based nanomateri-
als in E. coli is economically viable, important safety concerns related to the presence of endotoxins in the
products derived from this microorganism need to be addressed. Lactic acid bacteria (LAB) are a group of
food-grade microorganisms that have been classified as safe by biologically regulatory agencies. In this
context, we have demonstrated herein, for the first time, the production of fully functional, IB-like protein
nanoparticles in LAB. These nanoparticles have been fully characterized using a wide range of techniques,
including field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM),
dynamic light scattering (DLS), Fourier transform infrared (FTIR) spectroscopy, zymography, cytometry,
confocal microscopy, and wettability and cell coverage measurements. Our results allow us to conclude
that these materials share the main physico-chemical characteristics with IBs from E. coli and moreover
are devoid of any harmful endotoxin contaminant. These findings reveal a new platform for the produc-
tion of protein-based safe products with high pharmaceutical interest.
Statement of Significance
The development of both natural and synthetic biomaterials for biomedical applications is a field in con-
stant development. In this context, E. coli is a bacteria that has been widely studied for its ability to nat-
urally produce functional biomaterials with broad biomedical uses. Despite being effective, products
derived from this species contain membrane residues able to trigger a non-desired immunogenic
responses. Accordingly, exploring alternative bacteria able to synthesize such biomaterials in a safe
molecular environment is becoming a challenge. Thus, the present study describes a new type of func-
tional protein-based nanomaterial free of toxic contaminants with a wide range of applications in both
human and veterinary medicine.
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Over the last years, Escherichia coli has been described as a cell
factory for the production of self-assembling nanostructured and
functional protein materials known as inclusion bodies (IBs)
[1–4], which have been studied as stimulators of cell proliferation
and differentiation [5,6] and as natural protein delivery systems
[2,7]. However, in terms of therapeutic applicability of this bioma-
terial, the presence of lipopolysaccharide (LPS) in the E. coli outer
cell membrane becomes a major obstacle. Since LPS, also known
as endotoxin, can elicit undesirable immunogenic responses [8,9],
FDA regulations establish an endotoxin level limit of 5 EU/kg/h for
pharmaceutical compounds andmedical devices. Thus, all products
from E. coli, as well as those from other Gram-negative microorgan-
isms, need to be finely purified through costly processes to ensure
the removal of any pyrogenic or inflammatory contaminant inher-
ently present in the sample [8,10]. Nowadays, the development of a
universal and effective method for endotoxin removal remains for
the time being unresolved [10], being particularly critical for com-
plex structures such as protein-based nanostructured materials
[9,11]. This makes it necessary to seek for alternative cell factories,
which offer the potential to produce protein biomaterials free from
pyrogenic impurities. In this context, Gram-positive (LPS-free)
lactic acid bacteria (LAB) are gaining momentum as promising
microbial cell factories for both recombinant protein production
purposes and as delivery live vectors [12–16]. Indeed, they have
been classified by regulatory agencies as generally recognized as
safe (GRAS) organisms [17]. Consequently, the development of this
biologically-safe production platform based on LAB opens a new era
in terms of therapeutic applicability, leaving behind all the impor-
tant drawbacks associated to E. coli-derived recombinant products.
However, thus far, the possibility to produce protein-based nanos-
tructures in these bacterial cell factories has not been explored.
Contrary to what occurs in E. coli, it is widely believed that recom-
binant proteins produced in LAB are fully soluble, rendering the
production of protein-based biomaterials from these GRAS
microorganisms rather impossible. Nevertheless, some recent stud-
ies, such as that published by Lu and collaborators contradict this
general assumption [18]. They described that under the overex-
pression of a fluorescent protein, highly fluorescent protein clusters
are formed in Lactococcus lactis cytoplasm [18]. In this line, our
group confirmed the presence of protein deposits in L. lactis cyto-
plasm using a modified green fluorescent protein [19]. The consid-
eration of all these results together, lead us to believe that L. lactis
might potentially be used for the generation of fully safe protein-
based particles that could be further explored as functional
nanomaterials. Because almost nothing is known about these
nanostructures, the aim of this study was the isolation and detailed
characterization of the main morphometric and physico-chemical
properties of such a new class of protein deposits. For that, we
selected L. lactis, the most used LAB in the field of recombinant pro-
tein production as cell factory [20,21]. Three relevant proteins in
human and veterinary medicine such as bovine metalloproteinase
9 (MMP-9) and 2 (MMP-2) and interferon gamma (IFN-c) were used
herein as model proteins. The obtained data, which revealed the
possibility to produce both fully functional and safe protein-based
nanoparticles in LAB, offers an attractive opportunity for the pro-
duction of a new generation of biomaterials with a wide range of
biotechnology applications for both human and animal medicine.
2. Materials and methods
2.1. Bacterial strains and plasmids
L. lactis subsp. cremoris NZ9000 [20] and NZ9000 clpP htrA
(clpP-htrA; EmR) [22,23] (kindly provided by INRA, Jouy-en-Josas,France; patent n EP1141337B1) strains and E. coli MC4100 strain
(StrepR) [24] were used. Three proteins from bovine (Bos taurus) ori-
gin were cloned in the CmR pNZ8148 plasmid (MoBiTech): the
mature form of the interferon gamma (IFN-c) (from Gln23 to
Thr101 NM_173925) and the catalytic domain of metalloproteinase
9 (MMP-9) (from Phe107 to Pro449 NM_174744) and 2 (MMP-2)
(from Tyr110 to Asp45 NM_174745). In addition, a fusion of
MMP-9 with an aggregation-prone peptide (ELK16: (LELELKLK)2)
was also constructed (MMP-9ELK16). All genes were C-terminally
fused to a His-tag for detection and quantification purposes inwest-
ern blot analysis. Gene sequences were codon optimized (Geneart).
In the sequence designwe added aNcoI restriction site at 50 followed
by nucleotides CA to restore the reading frame and a XbaI restriction
site at 30. The digestion product was ligated into the expression
plasmid pNZ8148 and ligation product were transformed by
electroporation into L. lactis NZ9000 and clpP-htrA competent
cells [25]. Electroporation was performed using Gene Pulser from
Bio-rad fitted with 2500V, 200X and 25 lF in a pre-cooled 2 cm
electroporation cuvette. Following, samples were supplemented
with 900 lL M17 broth with 0.5% glucose and incubated for 2 h at
30 C. The electroporation mix was centrifuged for 10 min at
10,000g at 4 C and the pellet was resuspended in 100–200 lL of
M17 media and plated. Besides, recombinant Green Fluorescent
Protein (rGFP) previously described in [19,26] were also used.
2.2. Nanoparticle production and purification
L. lactis strains containing the previously described plasmids
were grown in M17 medium enriched with 0.5% glucose at 30 C
without shaking. E. coli was grown in LB rich medium at 37 C,
250 rpm. Nanoparticle production was induced by adding
12.5 ng/mL nisin (Sigma-Aldrich) in L. lactis or 1 mM IPTG in
E. coli cultures at OD550nm = 0.5. After induction, cultures were
grown for 3 h. Antibiotics were used for plasmid maintenance at
the following concentrations: chloramphenicol (5 lg/mL) and ery-
thromycin (2.5 lg/mL) for L. lactis and ampicillin (100 lg/mL) and
streptomycin (30 lg/mL) for E. coli.
Once produced, protein nanoparticles were purified using the
purification protocol described by [27], including, at the beginning
of the process, a mechanical disruption step by French Press. The
protocol was performed under sterile conditions and all incuba-
tions were carried out under agitation.
The amount of recombinant proteins present in nanoparticles
were quantified by denaturing SDS-PAGE as described in [19].
Bands were identified using a commercial polyclonal serum
against histidine tag (#A00186-100 Genscript) and an anti-
mouse secondary antibody (#170-6516, Bio-Rad). Recombinant
protein yield were estimated with a standard curve with known
amounts of a GFP-H6 protein. Quantification was performed with
the Quantity One software.
2.3. Field emission scanning electron microscopy (FESEM)
For nanoparticles morphometry (size and shape), microdrops of
protein aggregate suspensions were deposited during 2 min on sil-
icon wafers (Ted Pella Inc.), air-dried and observed in a FESEM
Zeiss Merlin (Zeiss) operating at 2 kV. Micrographs of nanoparti-
cles morphology at a nearly native state were acquired with a high
resolution in-lens secondary electron (SE) detector. A quantitative
analysis of particle size was performed with a total number of
474 nanoparticles using Image J software.
2.4. Transmission electron microscopy (TEM)
For ultrastructure, samples were fixed with aldehydes, post-
fixed with osmium, dehydrated in acetone, embedded in Epon
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Ultrathin sections were placed on copper grids, contrasted, and
observed with a TEM Jeol JEM-1400 (Jeol Ltd.) equipped with a
CCD Gatan ES1000W Erlangshen camera. For MMP-2, MMP-9
and IFN-c immunolocalization, pellets of bacterial cells and protein
nanoparticles were fixed in 4% (w/v) paraformaldehyde and 0.1%
(v/v) glutaraldehyde in PB, cryoprotected in sucrose, cryofixed in
propane, dehydrated in methanol, embedded in Lowicryl HM20
resin (Polysciences Inc.), and polymerized with UV rays. Ultrathin
sections placed on carbon-coated gold grids were labeled for the
3 antigens of interest using rabbit polyclonal primary antibodies
(anti-MMP-2: #AV20016, Sigma-Aldrich; anti-MMP-9: #50560-
RP01, Sino Biological Inc.; and anti-IFN-c: #ab9657, Abcam, at
working dilution 1:5, 1:5 and 1:2 respectively) and protein A cou-
pled to 10 nm-gold particles (BBI Solutions), following standard
methods [30,31]. Grids were contrasted and examined with a
TEM Jeol JEM-1400 at same conditions than previously described.
2.5. Z-Potential
Z-Potential characterization of each kind of protein nanoparti-
cles was carried out using dynamic light scattering (DLS) equip-
ment (Malvern Nanosizer). To prevent the electrodes from
burning, the samples were prepared in deionized (MilliQ) water,
a low ionic strength medium. Each sample was analyzed by
triplicate.
2.6. Proteinase K assay
Protein nanoparticles were resuspended in PBS and sonicated to
obtain a homogenous sample. Kinetic analysis were performed as
described in [32]. In control suspensions, MilliQ water was added
instead of Proteinase K. Sample was recovered after every mea-
surement to maintain constant the reaction volume. The experi-
ment was done by triplicate.
2.7. Mathematical modeling
The dynamics of nanoparticle disaggregation process is
described through a mixture of decreasing exponential functions
with up to 3 populations according to one of the following 2 mod-
els. If the protein of nanoparticles at time t is denoted by ymðtÞ, a
mixture without a constant population is given by
ymðtÞ ¼ N0ec1t þ . . . þ Nkeckt; m ¼ 2k; kP 1
denoted with an even subscript according to the even number of
terms. Otherwise, if there exist a non-disaggregated population,
the nanoparticle amount is given by
ymðtÞ ¼ N0 þ N1ec1t þ . . . þ Nkeckt ; m ¼ 2kþ 1; kP 1
with an odd subscript. In both cases the fit will depend on a set ofm
parameters P that is evaluated from a least squares fit. Only positive
values of Ni and ci are allowed. The parameter Ni is the initial pro-
tein of the i-th component and ci, in the exponent, provides the
expected life Ti ¼ 1=ci (the half-life is ti ¼ ln2=ci). The number of
components in the mixture model is C ¼ ½mþ12  (integer part). From
a data array L ¼ fðxi; tiÞ; i ¼ 1; . . . ; ng, where xi is the nanoparticle
amount at time ti, we minimize the v2 of the fit [32]. Among all
the possible fits, as increasing m we chose the one satisfying
. . . > v2m1 > v2m 6 v2mþ1.
In the context of the disaggregation process, not all fits are
admissible. Indeed, the procedure can be applied in 2 ways: (a)
as for each strain, the experiment is repeated q times, there is a
number of q arrays by strain that we averaged to build a single
array L ¼ EðLÞ (E means the expected value). We then determinedthe specific parameters P0 of the strain. (b) Alternatively, for each
strain, each experiment may be fitted separately. This provides q
families of parameter sets P that we averaged as P ¼ EðPÞ in order
to characterize the strain components. A meaningful fit must fulfill
that the values P and P 0 match within a low error margin. This is a
sufficient condition to accept the fitting, otherwise the strain aver-
age values E(L) would not represent the individual experiments. In
particular, this implies that the number of components of the
strain obtained from the average E(L) and that obtained for each
individual experiment must match. The necessary condition for
comparing both procedures is to determine the same number of
strain components C from the average array and the single arrays.
If both approaches provide a different number of strain compo-
nents, other fittings to reconcile both procedures must be chosen
among those with low v2, preferably among the simplest models,
although they do not provide the lowest value.2.8. Metalloproteinases activity assay (zymography)
MMP enzymatic activities were determined by gel 10% SDS-
PAGE +1% gelatin under non-denaturing conditions. IBs were
loaded onto the gel diluted 1:1 with a sample loading buffer
(0.125 M Tris, 0.005% bromophenol blue, 20% glycerol, 4% SDS).
Then, the gel was incubated with developing buffer (50 mM Tris,
0.2 M NaCl, 5 mM CaCl2, 0.02% Brij 35) for 48 h at 37 C. Lastly, it
was dyed with Coomassie and discolored until degradation bands
become visible. Densitometry analyses of the bands were per-
formed with the Image J software. Soluble MMP-9 produced in L.
lactis has been used as a positive control.2.9. Fourier transform infrared (FTIR) spectroscopy
The protein hydrated films were measured by the infrared
microscope Varian 610-IR, coupled to the Varian 670-IR spectrom-
eter (both from Varian Australia Pty Ltd.), as reported in [33,34]. In
particular, drops of 1–5 lL of the soluble protein and nanoparticles
were deposited on a BaF2 window. The FTIR spectra were then
collected in transmission mode after the solvent evaporation
in order to obtain a uniform protein film on the window. Under
these conditions [33,34] spectra with high signal-to-noise
ratio without detectable scattering effects were obtained [35]
(Suppl Fig. 1).
For hydrogen/deuterium (H/D) exchange experiments, the pro-
tein film on the BaF2 windowwas hydrate by adding 5 lL of a solu-
tion of 1/4 of glycerol/D2O ratio (w/w) around the dried film. The
sample was then tightly closed by a second window using a flat
O-ring.2.10. Proliferation assay
Human skin fibroblast cells (1BR3.G) were grown at 37 C and
10% CO2 on protein nanoparticles-decorated surfaces [36]. A total
of 1 lg of rGFP protein-based nanoparticles from L. lactis and
E. coli were added to each well of an untreated Costar 3370 plate
and incubated with 100 lL of Dulbecco’s Modified Costar Medium
(DMEM) without serum at 4 C overnight. After incubation, 1BR3. G
cells were added (5000 cells per well) in 100 lL DMEM medium
with 2% fetal bovine serum (FBS). As controls, we plated cells on
non-decorated wells and we also used wells decorated with
nanoparticles but without cells. Plates were incubated at 37 C
for 24, 48 and 72 h, and the MTT proliferation cell assay was per-
formed as described elsewhere [37].
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HeLa cells (60,000 cells per well) were seeded in treated 12-well
plates in the presence of Minimum Essential Medium (MEM-a)
medium supplemented with 10% FBS and 2 mM Glutamax (Gibco)
[30]. After incubation at 37 C and 5% CO2 for 24 h, the medium
was removed and the cells were washed with Dulbecco’s
Phosphate-Buffered Saline (DPBS). Then, 5 lg of rGFP based pro-
tein nanoparticles from L. lactis and E. coli were suspended in
MEM-a containing 10% FBS and 2 mM Glutamax and added per
well. After 48 h, cell samples were treated for 15 min in 1 mg/mL
trypsin and samples were analyzed on a FACSCanto system (Becton
Dickinson) using a 15W air-cooled argon-ion laser at 488 nm exci-
tation for GFP. Fluorescence emission was measured with a
530/30 nm band pass filter.
2.12. Nanoparticles internalization (confocal microscopy)
HeLa cells (100,000 cells/mL) were seeded on MatTek culture
dishes with MEM-a medium supplemented with 10% FBS and
2 mM Glutamax (Gibco), and incubated at 37 C and 5% CO2. 5 lg
rGFP nanoparticles were added to cells in the presence of Optipro
medium (Gibco) and incubated O/N. For confocal analysis, cell
membrane and nuclei were stained and stacks were obtained as
described elsewhere [38].
2.13. Modification of gold substrates with mixed self-assembled
monolayers (SAMs)
SAMs with different proportions of 1-undecenethiol (–CH3 ter-
minated) and 11-mercapto-1-undecanol (–OH terminated) were
prepared by immersion of gold substrates in an ethanolic solution
of the thiols with the appropriate molar ratio for 24 h as described
elsewhere [5].Then, the substrates were dried under a stream of N2
getting surfaces with different wettability properties.
2.14. Deposition of protein nanoparticles on SAM modified substrates
and surface covering analysis
Substrates with mixed SAMs were immersed in the protein
nanoparticles suspensions for 2 h, and rinsed with MilliQ water.
Light microscopy images were obtained using an Olympus Bx51
microscope and surface coverage analysis using ImageJ 1.47.Fig. 1. FESEM and TEM micrographs of L. lactis and purified nanoparticles. A) On the left,
MMP-9 nanoparticles inside (light grey particles). On the right, TEM immunolocalizati
micrographs 500 nm; lower micrographs 200 nm. B) FESEM micrographs of purified nan
bars: left inset 200 nm; right inset 100 nm; lower micrographs 500 nm.2.15. Wettability
The wettability of mixed thiols SAMs on gold surfaces before
and after protein nanoparticles deposition was determined via sta-
tic contact angle (CA) measurements using a DSA100 from KRÜSS.
2.16. Statistical analysis
Data were analyzed using a general linear model (JMP, SAS
Institute Inc.). For the analysis, strain, protein, and the interaction
between strain and protein were used as fixed effects. When more
than 2 means were compared, differences were established using
the Tukey’s multiple mean separation test. Data were previously
transformed when necessary to achieve a normal distribution.
Results are expressed as the means of non-transformed
data ± standard error of mean (SEM), except otherwise stated.
3. Results
3.1. Ultrastructural analysis of L. lactis nanoparticles by electron
microscopy
TEM micrographs obtained of L. lactis cells under overproduc-
tion conditions showed the formation of regular intracytoplasmic
protein deposits in practically all cells (Fig. 1A). Furthermore, the
specific immunolocalization confirmed that these deposits are
formed by the recombinant protein (Fig. 1A, right images). In a sec-
ond step, once the production of these protein deposits in L. lactis
was successfully assessed, MMP-9, MMP-2 and IFN-c nanoparticles
were isolated and quantified by Western blot (data not shown).
The ultrastructural morphology of the nanomaterial was analyzed
by FESEM and TEM (Fig. 1B and C) and the obtained micrographs
allowed us to conclude that these protein deposits corresponded
to well structured and compact-defined particles within the nanos-
cale range (Fig. 1B and C).
3.2. Size determination of L. lactis nanoparticles
By the analysis of FESEM micrographs, we determined the size
of the nanostructures, obtaining values ranging between 300 and
450 nm (Table 1). Extreme mean values were found for the
NZ9000 clpP htrA strain (hereafter called clpP-htrA), the lowest
mean values for the IFN-c and the highest one for the MMP-9FESEM micrographs of L. lactis bacteria. In the middle, TEM sections of L. lactis with
on of MMP-9 nanoparticles (labeled by anti-MMP-9) in L. lactis. Scale bars: upper
oparticles. Scale bars: 100 nm. C) TEM micrographs of purified nanoparticles. Scale
Table 1
Nanoparticle diameter, Z-potential and aggregation propensity. Measurements (mean ± standard error, in nm) done 3 h post-induction. Significant differences between all and
each productive strains are indicated by superscripts.
NZ9000 clpP-htrA SEM p value
MMP-9 IFN-c MMP-2 MMP-9-ELK16 MMP-9 IFN-c MMP-2 MMP-9-ELK16 Protein Strain Protein  strain
Diameter 353.21c,d 422.35a,b,c 387.54b,c 410.58a,b 431.58a 317.04d 391.84a,b,c 402.84a,b,c 13.91 0.2965 0.4895 <0.0001
Z-potential 29.6b,c 28.43b,c,d 33.83a 26.23c,d 30.77a,b 26.77c,d 27.5b,c,d 25.27d 0.70 <0.0001 0.012 0.0006
Aggregation (%) 99.24a,b 14.76a 92.13a,b 97.33c 98.27b,c 3.07b,c 100a 100a 0.18 0.0121 0.9947 <0.0001
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cles was determined by the combination of the specific protein and
the strain. Thus, MMP-9 round particles (Fig. 1B) were bigger in
clpP-htrA strain than those produced in wild type strain NZ9000
(Table 1). In marked contrast, more elongated IFN-c nanoparticles
(Fig. 1B) showed high variable size and shape and higher mean val-
ues when produced in the NZ9000 strain (Table 1).3.3. Electrodensity and immunolocalization analysis of L. lactis
nanoparticles
The internal ultrastructure reported by TEM (Fig. 1C) not only
strengthened the analysis performed by FESEM (Fig. 1B), but also
showed that the electrodensity of protein aggregates is again
protein- and strain-dependent. Interestingly, the electrodensity
and compactness observed by TEM (Fig. 1C) perfectly correlated
with the solubility of each protein (Table 1). The higher the solu-
bility of a protein was, the less prone to form protein nanostruc-
tures it was. Among tested proteins, IFN-c showed higher
solubility and its nanoparticles presented low electrodensity and
a less compact ultrastructure (Fig. 1C). Additionally, these parti-
cles, in marked contrast to what occurred with particles formed
by prone to aggregate proteins (such as MMPs, that formed highly
compact, smooth surface and round-shaped nanostructures),
exhibited rough surface and more variable size and shape
(Fig. 1B). To evaluate in more detail the distribution of the protein
forming such nanomaterial we performed an immunolocalization
of purified nanoparticles using TEM. Ultrathin section of central
parts of MMPs nanoparticles showed cortical electrodense parts
of the nanostructure (heavily labeled), whereas central and less
electrodense areas were less marked (or not marked) (Fig. 2). This
finding, observed both in nanoparticles located inside cells
(Fig. 1C) and in purified material (Fig. 2), was indicative of high
differences in protein concentrations in cortical and central parts
of nanoparticles.Fig. 2. TEM micrographs of purified nanoparticles labeled by specific antibod3.4. Study of the stability and supramolecular organization of L. lactis
nanoparticles
The structure and stability of the protein forming such nanoma-
terials were important parameters to be dissected. Z-potential
measurements showed that all nanoparticles present negatively
charged surfaces with large negative values ranging from 33 to
26 mV (Table 1), which is indicative of the stability of the suspen-
sion. To get further detail of supramolecular organization of
nanoparticles produced in L. lactis, a time-course of proteolytic
stability was performed (Fig. 3). After proteinase K treatment, the
three evaluated proteins showed a population susceptible to
degradation (population 1), with half-life values in the same
range for all proteins (Fig. 3). Besides, a fully resistant population
(population 2), ranging from 33% to 40%, was preserved. Thus,
nanoparticles produced in L. lactis presented two differentiated
populations in terms of proteolytic resistance (Fig. 3).3.5. Determination of L. lactis nanoparticles functionality in vitro
At this point it was critical to determine the biological activity
of the nanoparticles, produced and purified for the first time from
L. lactis. Fig. 4A shows that nanoparticles of proteins relevant for
human and veterinary medicine produced in L. lactis were biolog-
ically functional. All MMPs tested showed the ability to degrade
the substrate in a strain- and protein-dependent manner
(Fig. 4A). It is worth mentioning that it was also possible to mod-
ulate the conformational quality of the protein embedded in such
nanomaterials (Fig. 4A). The selection of the appropriate strain
would allow increasing the specific activity of L. lactis nanoparti-
cles, as it occurs with MMP-9. Besides, MMP-9 improves its specific
activity, just by the presence of an aggregation tag (ELK16) fused to
the protein (the observed activity corresponds to the activity of
0.08 ng of soluble MMP-9 protein). Moreover, the statistical analy-
sis indicated that the strain, combined with the protein used, areies. Scale bars: left and right inset 200 nm; lower micrographs 500 nm.
Fig. 3. Time-course stability of nanoparticles. MMP-9, IFN-c and MMP-2 produced in the clpP-htrA during proteinase K digestion (dark grey diamonds). Controls without
proteinase K (light grey squares). The standard error is represented by black lines at each time point. The values detailed in the table indicate the distribution of protein
populations in the nanoparticles according to their half-life under proteinase K treatment.
Fig. 4. Functionality of L. lactis protein-based nanoparticles. A) Specific activity of metalloproteinases. Different letters depict differences between proteins (P < 0.0001) and
due to the interaction between strain and protein (P = 0.0022). B) Biological effects of GFP nanoparticles on human mammalian cell cultures. Proliferation assay with 1BR3.G
cells cultured on surfaces decorated with 1 lg of GFP nanoparticles at 24, 48 and 72 h. Bars with asterisk differ (24 h, P = 0.0433; 48 h, P = 0.0008; 72 h, P = 0.0055) from
negative control. C) Percentage of fluorescent HeLa cells analyzed by cytometry after 24 h exposure to GFP nanoparticles. Significant differences depicted by asterisk
(P = 0.0010). D) Confocal micrographs of HeLa cells after 24 h exposure to GFP nanoparticles and their orthogonal sections in both the x and y axes. Scale bar in micrograph
represents 5 lm. In all cases, results are expressed as means of non-transformed data ±SE, which correspond to un-transformed data.
O. Cano-Garrido et al. / Acta Biomaterialia 43 (2016) 230–239 235important parameters to take into account in the production of
such functional protein delivery agents in safe production systems.
Interestingly, data obtained from the FTIR analysis confirmed
the coexistence of intermolecular b-sheets in nanoparticles (com-
ponents at around 1695 and 1627 cm1) with the presence of
native-like structures (Fig. 5 and Suppl Fig. 2) [33,34]. These two
populations perfectly correlated with the model mentioned above
(Fig. 2), in which resistant (intermolecular b-sheets) and sensitive
(native-like structures)-proteinase K populations coexisted in the
same nanostructure. As an example, the second derivative spectra
of MMP-9 and MMP-9-ELK16 were dominated by the marker
bands of intermolecular b-sheets in protein aggregates, but an
important component around 1658 cm1 was also present,indicating the occurrence of native-like a-helices and random coil
structures. The comparison of MMP-9 and MMP-9-ELK16 spectra
allowed concluding that MMP-9-ELK16 was characterized by a
lower level of aggregation, particularly in the case of clpP-htrA
sample. This was in agreement with a higher specific activity
observed for these nanoparticles (Fig. 4A).
The ability to stimulate cell proliferation is another interesting
property of IBs from E. coli. Interestingly, surfaces decorated with
the protein-based nanomaterial produced in L. lactiswere also able
to stimulate the proliferation of mammalian cells at a level similar
to that achieved by the particles produced in E. coli (Fig. 4B). More-
over, L. lactis nanoparticles were able to internalize inside the cells
even more efficiently than those produced in E. coli (Fig. 4C and D).
Fig. 5. FTIR analysis of purified nanoparticles. Second derivatives of absorption
spectra of A) MMP-9 and MMP-9-ELK16; the component around 1658 cm1 can be
assigned to a-helices and random coils and the two components at around
1633 cm1 and 1692 cm1 to the native intramolecular b-sheet structures of the
protein. B) IFN-c; the components around 1656 and 1681 cm1 can be assigned to
the native a-helices and to turn structures of the protein, respectively. C) MMP-2;
the component around 1637 cm1, along with the peak at 1692 cm1, can be
assigned to native, intramolecular b-sheets. The component around 1658 cm1 is
due to the native a-helices and to the random-coil structures of the protein. In A), B)
and C) the two components at around 1627 and 1695 cm1 are the typical marker
bands of intermolecular b-sheets in protein aggregates.
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nanoparticles
Because it has been already described that the hydrophilicity of
a surface influences cell adhesion properties [39], we determined
the nanoparticles wettability. Thus, the wettability of mixed self-
assembled monolayers (SAMs) on gold substrates before and after
being functionalized with L. lactis nanoparticles was determined
via contact angle (CA) measurements (Fig. 6). As expected, prior
to nanoparticle deposition the CA decreased as the hydrophilicity
of the SAM increased. An increase of 10% of the molar fraction
of OH-terminated thiols implied a decrease of 6 of the contact
angle of the SAM-covered substrates. However, after MMP-9nanoparticle deposition, the reduction of the contact angle in
response to a 10%-increase of the hydrophilic thiols concentration
relative to the hydrophobic one was smaller (4.0 in NZ9000 and
2.1 in clpP-htrA). Regarding MMP-2, after deposition of both
strains, the contact angle remained rather constant around 60,
which was an indication of its higher hydrophilic character. The
MMP-9-ELK16 presented different wettability properties
depending on the genetic variant it was obtained from. Thus,
MMP-9-ELK16 derived from the wild type strain rendered also a
constant contact angle around 60 but the one obtained from
clpP-htrA strain showed a reduction of 3 of the contact angle in
response to a 10%-increase of the hydrophilic thiols concentration.
After IFN-c deposition produced in both strains, the contact angle
remained rather constant at around 65–70. From the change of CA
after nanoparticle deposition, we concluded that the deposition of
nanoparticles produced in L. lactis buffered the change of
wettability of the substrates. On the other hand, IFN-c and
MMP-2 nanoparticles kept wettability relatively constant around
a certain value.
Coverages of nanoparticle surfaces are shown in Table 2. From
these data, it was possible to affirm that the affinity of protein
nanostructures toward hydrophilic and/or hydrophobic surfaces
also depended on the genetic background in which they have been
produced. Thus, the interactions between these protein-based bio-
materials and substrates, and the density of deposited nanoparti-
cles can be tuned to a certain extent choosing a specific L. lactis
strain. With MMP-2 and MMP-9-ELK16 there was a higher cover-
age and higher affinity of the nanoparticles towards the substrate
for the NZ9000 than for the genetically modified clpP-htrA. Regard-
ing the MMP-9 and the IFN-c, the potential difference between
NZ9000 and the mutant strain was not clear. The surface coverage
significantly varied also in response to changes of substrate wetta-
bility. For some proteins, high coverages were obtained for sub-
strates of different wettability, which could be attributed to the
presence of amphiphilic properties of the obtained nanoparticles.4. Discussion
E. coli IBs have been shown to be a mechanically stable nanoma-
terial with interesting properties as a drug delivery system, but
also as a promising biomaterial for tissue engineering. However,
the use of E. coli as recombinant cell factory for their production
has an important shortcoming. Because of their endotoxic nature
due to the presence of LPS, even at low concentration, IBs can trig-
ger a non-desired immunogenic response upon administration.
Therefore, any E. coli-derived product have to be necessarily fur-
ther purified through a time-consuming, costly, and, in many cases,
ineffective depyrogenation process [14]. For this reason, and with
the goal of producing protein-based biomaterials in an
endotoxin-free environment, we explored L. lactis as cell factory.
Although L. lactis has already been proven to be an excellent choice
for the production of other LPS-free biomaterials such as
polyhydroxybutyrate (PHB), the main mechanical and chemical
properties of protein-based nanostructures produced in this
Gram-positive microorganism have never been studied. Thus, the
present study shows for the first time an accurate analysis of a
novel protein-based nanomaterial produced in a safe cell factory,
which sets the basis to further explore the applicability of this
platform to produce biomaterials for the pharmaceutical industry.
As starting point, we successfully produced and isolated such
nanomaterial from L. lactis. The obtained nanoparticles were care-
fully assessed by high resolution microscopy techniques, noticing
that proteins acting as building blocks of these nanoparticles are
heterogeneously distributed within the nanomaterial (Fig. 2). In
particular, immunolocalization analysis revealed high differences
Fig. 6. Contact angle measurements. Contact angles of 6 different functionalized gold surfaces, containing different molar ratio of –OH terminated (XOH) alkanethiols. Surfaces
before nanoparticle deposition (dark grey diamond) and after nanoparticle deposition (light grey square).
Table 2
Percentage of area covered with nanoparticles of SAMs functionalized gold substrates. Dependence of the nanoparticle coverage on the functionalized gold substrate wettability
for the different proteins obtained from different genetic strains.
Substrate (XOH) MMP-9 IFN-c MMP-2 MMP9-ELK16
NZ9000 clpP-htrA NZ9000 clpP-htrA NZ9000 clpP-htrA NZ9000 clpP-htrA
0 0.14 1.54 0.41 0.47 6.31 2.74 11.44 5.32
0.2 0.22 0.89 0.40 1.31 5.61 1.74 19.36 3.46
0.4 0.23 1.66 0.68 0.4 5.26 2.75 14.73 5.70
0.6 0.58 0.61 1.91 0.23 10.38 1.03 15.02 11.24
0.8 0.20 1.56 2.17 0.29 12.05 0.81 4.26 4.27
1 0.39 0.37 1.39 0.43 15.14 3.30 13.70 1.14
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ticles, with cortical regions being much richer in protein than
particle core ones. This was probably related to the activity of cell
mechanisms during nanostructure formation and growth, previ-
ously observed in IB formation [30]. In addition, the ultrastructure
observed by FESEM and TEM (Fig. 1 and Table 1) also resembled
that of IBs formed in E. coli [3,30,40]. Interestingly, our data proved
that nanoscale features such as size, compactness and shape can be
easily tailored by selecting the appropriate combination of protein
and strain (Table 1, Fig. 1B and C). The interaction between strain
and protein had also a clear effect on the biological activity of
our nanoparticles (Fig. 4A). This finding opens a range of
possibilities in the customization of this functional and safe
biomaterial. This is particularly interesting considering that theseprotein-based nanomaterials can be also genetically engineered,
being possible not only to define size, shape and electrodensity,
but also the organization and the biological activity of the
produced protein-based nanoparticles in this safe microorganism.
Considering the enzymatic activity of MMP nanoparticles obtained
herein (Fig. 4A) and their ability to stimulate cell proliferation
(Fig. 4B), this biomaterial has a great potential for both drug
delivery (Fig. 4A) and tissue engineering purposes (Fig. 4B).
It has also been described that E. coli IBs show a bimodal
supramolecular organization of the embedded protein. In this case,
E. coli IBs contain a fraction of protein ranging from 9 to 33% with
an amyloid-like organization, which is fully resistant to proteinase
K and acts as a nanoparticle scaffold, and two other protein popu-
lations, one of them being immediately degraded and another one
238 O. Cano-Garrido et al. / Acta Biomaterialia 43 (2016) 230–239sensitive to proteinase K digestion being associated with the bio-
logical activity shown by IBs [32]. The food-grade nanomaterial
characterized in the present study exhibited a degradable popula-
tion, with a half-life comparable to the populations described in
E. coli [32], and a resistant population (Fig. 3). The coexistence of
these two distinguished populations was further confirmed by FTIR
analysis (Fig. 5). Proteins adopting an intermolecular b-sheet con-
formation would correspond to the proteinase-K resistant popula-
tion, whereas proteinase-K sensitive population exhibited a native-
like structure which contributed to its remarkable biological
activity.
The determination of the chemical properties of these nanopar-
ticles also supports that such nanoclusters have many characteris-
tics in common with those obtained when using E. coli as cell
factory. Depending on the genetic background chosen to produce
the nanoparticles, the wettability properties of the nanostructures
and thus, the wettability of surfaces modified with them, can be
modulated [5]. Besides, the presence of a simple aggregation tag,
such as ELK16 in MMP-9, clearly modifies the behavior of the
nanostructure. However, Z potential values of L. lactis-derived
nanoparticles determined in this study are higher than those
observed in IBs produced in LPS-enriched environment [5], indicat-
ing that, although endotoxin-free nanostructures share many char-
acteristics with those derived from E. coli, they are more stable in
suspension.
Considering E. coli limitations, this study opens a range of pos-
sibilities in terms of applications. The implementation of LAB as a
routine cell factory for the production of functional nanomaterials
would allow the development of safe production processes, avoid-
ing at the same time complex downstream purification steps to
eliminate toxic components.5. Conclusions
Data presented in this study reveal for the first time, that it is
possible to produce, tune and isolate endotoxin-free IB-like
nanoparticles from LAB through a cost-effective and fully scalable
process. The results provide evidence that under overexpression
conditions, L. lactis is able to produce protein nanoparticles bearing
similar properties than those produced in E. coli. Interestingly,
these functional nanostructures isolated from L. lactis show even
higher stabilities and activity than those obtained from E. coli. This
finding allows making a qualitative step, since it opens a field of
opportunities for the production of recombinant proteins in a
cost-effective format using GRAS systems as cell factories. Overall,
these data indicate that LAB are ideal alternatives for the synthesis
of tuned protein-based endotoxin-free nanoparticles for a wide
range of applications in both human and veterinary medicine.Acknowledgements
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